Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway
Imported from official source
Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today.
This version
- Version
- 1 of 1
- Recorded
- November 09, 2026 10:02
- Change
- Initial
- Content hash
5375e8e0c43caeceea3c1920d4a2d27c- All versions
- Revision history